Aug 31 (Reuters) - Medigard Ltd (MGZ) : FY revenues from continuing operations $65,295, up 47 percent FY profit attributable $79,252 versus $81,020
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
